Difference between revisions of "Section 3: Results (from DOI: 10.1016/j.adro.2020.04.015) (Q11169)"
Jump to navigation
Jump to search
(Created claim: named entity (P78): Fatigue (disease - MeSH descriptor) (Q8307), #quickstatements; #temporary_batch_1593384233780) |
(Created claim: named entity (P78): durvalumab (chemical - MeSH supplementary concept) (Q11114), #quickstatements; #temporary_batch_1593384233780) |
||
| Property / named entity | |||
| + | |||
| Property / named entity: durvalumab (chemical - MeSH supplementary concept) / rank | |||
| + | Normal rank | ||
Revision as of 22:44, 28 June 2020
Publication: "Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic"published as Adv Radiat Oncol; 2020 May 05; DOI: 10.1016/j.adro.2020.04.015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Section 3: Results (from DOI: 10.1016/j.adro.2020.04.015)
|
Publication: "Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic"published as Adv Radiat Oncol; 2020 May 05; DOI: 10.1016/j.adro.2020.04.015
|
Statements
0 references
0 references
0 references
0 references
0 references
0 references
0 references
